PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $245,288 | -46.5% | 213,294 | -50.7% | 0.00% | -50.0% |
| Q1 2023 | $458,700 | -32.3% | 432,736 | -3.0% | 0.00% | -33.3% |
| Q4 2022 | $677,765 | -35.7% | 445,898 | -10.3% | 0.00% | -40.0% |
| Q3 2022 | $1,054,000 | +28.4% | 497,190 | -18.9% | 0.01% | +25.0% |
| Q2 2022 | $821,000 | -38.1% | 612,701 | -2.6% | 0.00% | -20.0% |
| Q1 2022 | $1,327,000 | -47.3% | 628,901 | -7.4% | 0.01% | -44.4% |
| Q4 2021 | $2,519,000 | -2.9% | 679,072 | +30.6% | 0.01% | -25.0% |
| Q3 2021 | $2,595,000 | – | 520,087 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |